drugset / Trial / NCT00503763

Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma

NCT00503763

Phase 2 Withdrawn Meir Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the effect of statin administration on the course of progressive Smoldering Multiple Myeloma.

Timeline

Start
2007-09
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 80 mg Oral